Arizona Bioscience News: UA startup’s eye-testing device; TGen works with Mexican researchers on precision medicine; Barrow Neurological Institute to study new drug

July 18, 2019

By Matt Ellsworth

UA startup developing hand-held eye testing device / Arizona Daily Star 

University of Arizona scientists have formed the startup iCrx Inc. to perfect a new instrument to determine eye prescriptions faster and more accurately—in a portable, hand-held device with the promise of extending eye care to millions of people worldwide. 


Cross-border efforts focused on medical breakthroughs for Hispanics / Chamber Business News 
 
Translational Genomics Research Institute and the Institute for Genomic Medicine of the Mexican National Institutes of Health in Mexico City are working on projects to advance precision medicine, including diagnosing rare childhood disorders, detecting breast cancer genes, and finding genetic markers for coronary heart disease in Mexican-Americans. 


Could Karyopharm’s newly approved multiple myeloma drug also work in glioblastoma? / FierceBiotech 
 
The Ivy Brain Tumor Center at the Barrow Neurological Institute in Phoenix has formed a partnership with Karyopharm Therapeutics to study its new product, Xpovio, in adult glioblastoma, a form of brain cancer that has proven particularly difficult to target with drugs. 


HonorHealth hits construction milestone with new Valley hospital / AZ Big Media 
 
HonorHealth celebrated the topping out of the construction on its sixth Valley hospital, the $170 million, 210,000-square-foot HonorHealth Sonoran Medical Center in north Phoenix, set to open in September 2020. 


A genetic test that reveals Alzheimer’s risk can be cathartic or distressing / NPR 
 
The Banner Alzheimer’s Institute in Phoenix is enabling research study participants to learn whether they have the gene that is the most powerful known genetic risk factor for Alzheimer’s disease after age 65. 


Neuroscience team discovers neurons that regulate eating behaviors / Daily Wildcat 
 
University of Arizona researchers have discovered neurons within the brain that control one’s urge to eat in response to inflammation, which may provide a new target for treating anorexia and other eating disorders. 


Canine cancer vaccine trial at ASU could possibly save millions of dogs / Fox 10 

Arizona State University is working with three other universities and using a $6.4 million grant to develop a canine-cancer vaccine that could potentially save the lives of millions of dogs.   


Upcoming Events

Aug. 12: SBIR Road Tour 2019, UA Tech Park Event Center, Tucson 

Aug. 22: AZBio Summer Social 2019, GlobalMed, Scottsdale 

Sept. 4-5Rocky Mountain Life Science Investor and Partnering Conference, Vail, Colo.  


Sign up to receive Arizona Bioscience News weekly